Prevalence and impact of antisperm antibodies on semen quality and male reproductive health aspects: A 10‐years retrospective study
Andrology · 2025
DOI: 10.1111/andr.70020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Andrology, 2025. Verfasst von Andreia Filipa Neves Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Interdisciplinary Research, Doctoral Programme in Experimental Biology and Biomedicine (PDBEB) University of Coimbra, Coimbra, Portugal. Hauptthemen laut MEDLINE: Spermatozoa, Infertility, Male, Autoantibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: European Regional Development Fund (ERDF), Operational Programme for Competitiveness and Internationalisation (COMPETE 2020) and Portuguese national funds via FCT- Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
Background
The association between antisperm antibodies (ASA) and male (in)fertility is not fully understood, mainly due to contradictory reports. However, there is indication that ASA might affect several male reproductive health aspects warranting further investigation.
Objective
To investigate the prevalence and impact of ASA on semen quality and its association with male reproductive function. Materials and methods ASA presence was evaluated by the MAR test. Their prevalence, impact on semen quality and several aspects of male reproductive function were assessed, retrospectively, in a cohort of 2727 men, divided in 4 groups according to the percentage of ASA (without ASA, 10%–49% ASA, ≥50% ASA, and 10%–100% ASA).
Results
The prevalence of ASA was 1.4%. When compared to the group without ASA, patients with ≥50% ASA, presented a higher percentage of semen agglutinates and leukocytes, and higher testicular volume. Subjects with 10%–49% and 10%–100% ASA, had lower levels of FSH and fructose, and higher levels of estradiol, α‐glucosidase, and higher testicular volume. Furthermore, the 10%–49% ASA group presented a higher agglutination and percentage of round cells and leukocytes, when compared with the group without ASA. Similar results were observed in the 10%–100% ASA group. Interestingly, smoking habits were more frequent in the ≥50% ASA group, compared with the 10%–49% ASA group, with the chance of having ASA at a pathological level being 2‐fold higher. Discussion and conclusion In this study, data on ASA prevalence, impact in semen quality and on several aspects of male reproductive health were analyzed in one of the biggest and thoroughly characterized cohorts so far. Agglutination and impaired motility remain the most revealing parameters of ASA presence and should be considered in the clinical ASA management. Interestingly, we are the first to report an association between smoking and pathological ASA levels. The reported higher testicular volume and lower FSH in ASA patients may be of clinical relevance, suggesting that ASA might also have a role in the impaired fertility, highlighting the importance of ASA testing especially in men with lacking etiologic factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Interdisciplinary Research, Doctoral Programme in Experimental Biology and Biomedicine (PDBEB) University of Coimbra, Coimbra, Portugal.
- CNC-UC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
- CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.
- Department of Clinical and Surgical Andrology, Centre of Reproductive Medicine and Andrology, University of Münster, Münster, Germany.
- Institute of Reproductive and Regenerative Biology, Centre of Reproductive Medicine and Andrology, University of Münster, Münster, Germany.
- Department of Life Sciences, Faculty of Sciences and Technology, University of Coimbra, Coimbra, Portugal.
ORCID-Profile: Maria Schubert, Stefan Schlatt
Förderung
- European Regional Development Fund (ERDF)
- Operational Programme for Competitiveness and Internationalisation (COMPETE 2020) and Portuguese national funds via FCT- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Silva, A. F. N., Schubert, M., Kliesch, S., Schlatt, S., Ramalho-Santos, J., & Amaral, S. C. G. (2025). Prevalence and impact of antisperm antibodies on semen quality and male reproductive health aspects: A 10‐years retrospective study. Andrology. https://doi.org/10.1111/andr.70020
Vancouver
Silva AFN, Schubert M, Kliesch S, Schlatt S, Ramalho-Santos J, Amaral SCG. Prevalence and impact of antisperm antibodies on semen quality and male reproductive health aspects: A 10‐years retrospective study. Andrology. 2025. doi:10.1111/andr.70020
BibTeX
@article{Silva2025,
author = {Silva, Andreia Filipa Neves and Schubert, Maria and Kliesch, Sabine and Schlatt, Stefan and Ramalho-Santos, Joao and Amaral, Sandra Catarina Gomes},
title = {Prevalence and impact of antisperm antibodies on semen quality and male reproductive health aspects: A 10‐years retrospective study},
journal = {Andrology},
year = {2025},
doi = {10.1111/andr.70020}
}
EUVIMED